This radiopharmaceutical has got an excellent and unique functioning for bone metastasis pain relief.
This radiopharmaceutical is injected into a vein and distributed throughout the body, and it is absorbed in areas where the cancer has invaded the bone. The Sm 153 radioisotope, with a half-life of 46.3 hours, kills tumor cells and greatly reduces pain by emitting high-energy beta particles. After the injection, the patient begins to recover in the first week and the healing effects may last for several months. This radiopharmaceutical is commonly used to treat bone metastatic pain in lung cancer, prostate cancer, breast cancer and osteosarcoma.